International Chemical Investors Group (ICIG) has entered into an agreement for to acquire Roche Colorado Corp., which includes Roche’s pharmaceutical production facility in Boulder, CO. The acquisition covers approximately 265 employees and includes technical development and small molecule manufacturing capabilities. Financial terms were not disclosed. ICIG plans to operate the Boulder site as Corden Pharma Colorado Inc., a component of its Corden Pharma organization; it will initially supply ...